Loading clinical trials...
Loading clinical trials...
A Multi Site, Open Label, Parallel Group Study to Assess Changes in Tobacco Related Biomarkers of Exposure Following Switching From Smoking of Combustible Cigarettes to Exclusive Use of Nicotine Pouches in Adult Smokers
Conditions
Interventions
Nicotine Pouch P1312914, 4 mg nicotine
Nicotine Pouch P1312915, 8 mg nicotine
+5 more
Locations
5
United States
Pillar Bentonville
Bentonville, Arkansas, United States
AMR Lexington
Lexington, Kentucky, United States
QPS Missouri
Springfield, Missouri, United States
AMR Knoxville
Knoxville, Tennessee, United States
Pillar Richardson
Richardson, Texas, United States
Start Date
August 22, 2024
Primary Completion Date
January 15, 2025
Completion Date
January 15, 2025
Last Updated
April 11, 2025
NCT06372899
NCT07441928
NCT06264154
NCT07214168
NCT07322796
NCT07312552
Lead Sponsor
RAI Services Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions